• $7.9M
    Market Cap
  • -60.70%
    1-Year Change
  • Pharmaceutical Retailers
    Industry
Annual
Quarterly
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
13.2M
-61.11%
33.8M
N/A
Cost of Revenue
6.8M
-56.43%
15.6M
N/A
Gross Profit
6.2M
-64.86%
17.7M
N/A
Sales and Marketing Expense
18.6M
-38.68%
30.3M
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
732,000
-62.27%
1.9M
N/A
Total Operating Expenses
826,000
-97.41%
31.9M
N/A
Operating Profit
5.4M
+137.89%
-14.2M
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
-2.1M
-43.79%
-3.8M
N/A
Interest Income and Expense and Net
-2.1M
-43.79%
-3.8M
N/A
Total Nonoperating Income and Expense
12.9M
+187.10%
4.5M
N/A
Income before Taxes
18.3M
+288.70%
-9.7M
N/A
Income Taxes
1.4M
-65.57%
4.1M
N/A
Extraordinary Items
1.7M
N/A
0
N/A
Net Income
33.1M
+334.24%
-14.1M
N/A
Net Income from Continuing Operations Applicable to Common
18.3M
+288.70%
-9.7M
N/A
Basic EPS and Net Income
N/A
N/A
-1.72
N/A
Diluted EPS and Net Income
N/A
N/A
-1.72
N/A
Basic Weighted Average Shares
8.5M
+3.73%
8.2M
N/A
Diluted Weighted Average Shares
13.4M
+63.48%
8.2M
N/A
Balance Sheet
Cash and Cash Equivalents
1.0M
+20.65%
862,000
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1.0M
+20.65%
862,000
N/A
Total Current Assets
2.9M
-38.82%
4.7M
N/A
Accumulated Depreciation
454,000
-90.85%
5.0M
N/A
Property and Plant and Equipment and Net
267,000
-97.27%
9.8M
N/A
Total Long-Term Assets
0
-100.00%
10.5M
N/A
Total Assets
24.8M
-22.61%
32.1M
N/A
Income Taxes Payable
13.3M
-20.68%
16.7M
N/A
Total Short-Term Debt
650,000
-97.12%
22.6M
N/A
Total Current Liabilities
9.7M
-84.56%
62.5M
N/A
Total Long-Term Debt
2.3M
-64.27%
6.5M
N/A
Total Long-Term Liabilities
11.8M
-23.13%
15.3M
N/A
Total Liabilities
29.6M
-61.98%
77.8M
N/A
Retained Earnings
-421.1M
-7.29%
-454.2M
N/A
Total Stockholders Equity
-6.7M
-85.23%
-45.7M
N/A
Total Shares Outstanding
13.6M
+59.28%
8.5M
N/A
Cash Flow
Cash from Operating Activities
-1.5M
+15.68%
-1.3M
N/A
Capital Expenditures
10,000
-96.88%
321,000
N/A
Cash from Investing Activities
2.0M
+339.39%
462,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
143,000
-73.47%
539,000
N/A
Financials Ratio
Gross Margin
48.45%
N/A
N/A
N/A
Operating Margin
40.91%
N/A
N/A
N/A
Return on Assets
116.36%
N/A
N/A
N/A
Return on Equity
-126.22%
N/A
N/A
N/A
Revenue Growth
-61.11%
N/A
N/A
N/A
Current Ratio
0.30
N/A
N/A
N/A
Cash Ratio
0.11
N/A
N/A
N/A
Debt-to-Equity Ratio
-0.44
N/A
N/A
N/A
Debt-to-Assets Ratio
0.12
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow